Introduction {#sec1}
============

Tuberculosis (TB) caused by *Mycobacterium tuberculosis* (*M. tuberculosis* or *M. tb*) is mainly a disease of the lungs mostly of pulmonary type tuberculosis (PTB), which can easily be spread to others by coughing and breathing. Regardless of availability of various effective treatment strategies, which were assumed to eliminate this disease, recent epidemiological figures of the year 2016 shown that TB is once more on the upsurge \[[@B1]\]. Globally, there is a large burden of disease with 9.6 million new cases and 1.5 million people are reported to deaths in the year 2014 \[[@B1]\].

Approximately one-third of the world's population is thought to be affected with *M. tuberculosis* but relatively large number of population remains with no clinical sign of the disease. However, remaining 5--15% of the infected individuals develop active disease later in life \[[@B2]\]. This suggests that besides *Mycobacteria* itself, the host genetic factors may regulate the differences in host susceptibility to TB \[[@B3]\]. The identification of host genes and genetic variations that are important in susceptibility and resistance to tuberculosis would lead to a better understanding of the pathogenesis of PTB and perhaps lead to new approaches of the disease treatment or prophylaxis.

Immune response to PTB is regulated by interactions between lymphocytes with antigen-presenting cells and the cytokines secreted by these cell types. Cytokines, their genes and receptors have been implicated in the protective immunity, pathophysiology and in the development of tuberculosis \[[@B4]\]. Manifestation of clinical PTB depends on balance between *T helper 1* (*Th1*) cytokines associated with resistance to infection and *Th2* cytokines with progressive disease \[[@B5]\].

*IL-10* gene maps on the long arm of chromosome 1 (1q31-1q32) locus and produced by both myeloid cells and T cells. *IL-10* signals through a receptor complex consisting of two subunits: *IL-10*R1, induced on stimulated hematopoietic cells, and the *IL-10*R2, constitutively expressed on most cells and tissues \[[@B6]\].

*IL-10*, an anti-inflammatory cytokine prevents the protective immune response to pathogens by blocking the production of proinflammatory cytokines, such as *TNF-α* and *Th1*-polarizing cytokine IL-*12*, by directly acting on antigen-presenting cells such as macrophages and dendritic cells \[[@B7]\]. *IL-10* may also inhibit phagocytosis and microbial killing by limiting the production of reactive oxygen and nitrogen intermediates in response to *IFN-γ* and *Th1* induced response to TB \[[@B8],[@B9]\]. *IL-10* was shown to be elevated in the lungs and serum of PTB patients \[[@B10]\].

The production of cytokines can be modulated both by the stimuli present in the local environment as well as by the genetic factors. Both, *in vitro* and *in vivo* studies have demonstrated that the presence of polymorphisms within the coding or noncoding sequences of cytokine genes can alter the efficiency of transcription of these genes and thus the production of cytokines. Interindividual variations in *IL-10* production are genetically contributed by polymorphisms within the promoter region. The polymorphism -1082 A\>G occurs within a putative Ets (E26 transformation-specific) transcription factor-binding site and may affect the binding of this transcriptional factor and therefore altered levels of this cytokine and may alter *Th1*/ *Th2* balance with major implications in tuberculous infection \[[@B11],[@B12]\].

A number of clinical and genetic studies have been performed to consider the effect of *IL-10* -1082 A\>G (rs1800896) gene polymorphism on the development of PTB \[[@B13]--[@B34]\]. Results published from previous studies are either conflicting or contradictory in nature and still it is unclear whether this polymorphism is associated with increased or decreased risk of PTB infection \[[@B13]--[@B34]\]. Inconsistency in the results across many of the studies could possibly be due to the ethnicity of the population, sample size, and individual studies that have low power to evaluate the overall effect. To overcome this situation, nowadays meta-analysis statistical tool is in use to explore the risk factors associated with the genetic diseases, because it employs a quantitative method of pooling the data collected from individual studies where sample sizes are small to provide reliable conclusions. Hence, in the present study, a meta-analysis was performed to evaluate the effect of *IL-10* -1082 A\>G gene polymorphism on the risk of overall PTB development and its ethnicity-wise distribution.

Materials and methods {#sec2}
=====================

Literature search strategy {#sec2-1}
--------------------------

We performed a PubMed, Medline, EMBASE, and Google Scholar web databases search covering all research articles published with a combination of the following key words, i.e. *IL-10, Interleukin-10* gene (polymorphism OR mutation OR variant) AND tuberculosis susceptibility or TB or Pulmonary tuberculosis or PTB (last updated on June 2016). We examined potentially pertinent genetic association studies by examining their titles and abstracts, and procured the most relevant publication matching with the eligible criteria for a closer examination. Besides the online database search, the references given in the selected research articles were also screened for other potential articles that may have been missed in the primary search.

Inclusion and exclusion criteria {#sec2-2}
--------------------------------

In order to minimize heterogeneity and facilitate the proper interpretation of this study, published articles included in the current meta-analysis had to meet all the following criteria, i.e. they must have done case--control studies between *IL-10*-1082 A\>G gene polymorphism and PTB risk,clearly described confirmed PTB patients and PTB free controlshave available genotype frequency in the both cases and controlspublished in the English languagedata collection and analysis methodology should be statistically acceptableadditionally, when the case--control study was included in more than one research article using the same subject series, we selected the research study that incorporated the largest number of individuals.

The major reasons for study exclusion were: duplicate or overlapping publicationstudy design based on only PTB casesgenotype frequency not reporteddata of review or abstract

Data extraction and quality assessment {#sec2-3}
--------------------------------------

For each retrieved study, the methodological quality assessment and data extraction were independently abstracted in duplicate by two independent investigators (SAD & RKM) using a standard protocol. Data collection form was used to confirm the accuracy of the collected data by strictly following the inclusion/exclusion criteria as stated above. In case of disagreement between the above mentioned two investigators on any item related with the data collected from the selected studies, the issue was fully debated and deliberated with the investigators to attain a final consensus. Also, in case failure of reaching consensus between the two investigators, an agreement was achieved following an open discussion with the adjudicator (SH). The major characteristics abstracted from the retrieved publications included the name of first author, publication year, the country of origin, source of cases and controls, number of cases and controls, study type, genotype frequencies, and association with pulmonary TB.

Quality assessment of the included studies {#sec2-4}
------------------------------------------

Methodological quality evaluation of the selected studies was performed independently by two investigators (RKM & SAD) by following the Newcastle--Ottawa Scale (NOS) of quality assessment \[[@B35]\]. The NOS quality assessment criteria included three major aspects: (i) subject selection: 0--4 points, (ii) comparability of subject: 0--2 points, and (iii) clinical outcome: 0--3 points. Selected case--control studies that gained five or more stars were considered as of moderate to good quality \[[@B36]\].

Statistical analysis {#sec2-5}
--------------------

In order to evaluate the association between the *IL-10* -1082 A\>G gene polymorphism and risk of developing PTB, pooled ORs and their corresponding 95% CIs were estimated. Heterogeneity assumption was examined by the chi-square-based *Q*-test \[[@B37]\]. Heterogeneity was considered significant at *P*-value \< 0.05. The data from single comparison were combined using a fixed effects model \[[@B38]\], when no heterogeneity was obtained. Otherwise the random-effects model was used for the pooling of the data \[[@B39]\]. Moreover, *I*^2^ statistics was employed to quantify interstudy variability and larger values suggested an increasing degree of heterogeneity \[[@B40]\]. Hardy--Weinberg equilibrium (HWE) in the controls was calculated by chi-square test. Funnel plot asymmetry was measured by Egger's regression test, which is a type of linear regression approach to measure the funnel plot asymmetry on the natural logarithm scale of the OR. The significance of the intercept was measured by the *t*-test (*P*-value \< 0.05 was considered as a representation of statistically significant publication bias).

A comparative assessment of 'meta-analysis' based programs was done by using weblink <http://www.meta-analysis.com/pages/comparisons.html>. The Comprehensive Meta-Analysis (CMA) Version 2 software program (Biostat, U.S.A.) was utilized to perform all the statistical analysis involved in this meta-analysis.

Results {#sec3}
=======

Characteristics of the published studies {#sec3-1}
----------------------------------------

A total of 22 articles were lastly selected after literature search from the PubMed (Medline), EMBASE, and Google Scholar web databases. All retrieved articles were inspected carefully by reading their titles and abstracts, and the full-texts for the potentially relevant publications were further checked for their aptness of inclusion in this meta-analysis ([Figure 1](#F1){ref-type="fig"}: PRISMA 2009 Flow Diagram). All the included 22 studies follow the preset eligible criteria of the study inclusion and clearly stated about sample sizes, genotypes, inclusion criteria of PTB patients, and healthy controls. All the studies included in this meta-analysis had recruited HIV free subjects.

![PRISMA flow-diagram\
The selection process (inclusion/exclusion) of the studies dealing with *IL10* -1082 A\>G (rs1800871) gene polymorphism and PTB risk.](bsr-37-bsr20170240-g1){#F1}

Research articles either showing *IL-10* polymorphism to predict survival in PTB patients or considering *IL-10* variants as indicators for response to therapy were excluded straightaway. Similarly, studies investigating the levels of *IL-10* mRNA or protein expression or relevant review articles were also excluded from this meta-analysis. We included only case--control or cohort design studies stating the frequency of all three genotypes. Besides the database search, the supporting references available in the retrieved articles were also checked for other potential studies. After careful screening and following the inclusion and exclusion criteria, 22 eligible original published studies were finally considered for the present study ([Table 1](#T1){ref-type="table"}). Distribution of genotypes, HWE *P*-values in the controls, and susceptibility toward PTB have been shown in [Table 2](#T2){ref-type="table"}. All the selected studies (22 in number) were examined for the overall quality following the NOS and most of the studies (\>80%) scored five stars or more, indicating a modest to good quality ([Table 3](#T3){ref-type="table"}).

###### Main characteristics of all studies included in the present meta-analysis

  First author and year \[Ref.\]             Country     Ethnicity   Controls   Cases   Study    Genotyping technique
  ------------------------------------------ ----------- ----------- ---------- ------- -------- ----------------------
  Hu et al., 2015 \[[@B13]\]                 China       Asian       480        120     HB       ARMS PCR
  Feng et al., 2014 \[[@B14]\]               China       Asian       191        191     HB       PCR-RFLP
  García-Elorriaga et al., 2013 \[[@B15]\]   Mexico      Mixed       47         40      HB       TaqMan
  Akgunes et al., 2011 \[[@B16]\]            India       Asian       30         30      HB       PCR Probe
  Liang et al., 2011 \[[@B17]\]              China       Asian       78         112     HB       SNaPshot assay
  Ansari et al., 2011 \[[@B18]\]             Pakistan    Asian       166        102     HB,PB    ARMS PCR
  Ben-Selma et al., 2011 \[[@B19]\]          Tunisia     African     95         76      HB       ARMS PCR
  Taype et al., 2010 \[[@B20]\]              Peru        Caucasian   510        500     PB       PCR-RFLP
  Mosaad et al., 2010 \[[@B21]\]             Egypt       African     98         26      HB       ARMS PCR
  Thye et al., 2009 \[[@B22]\]               Ghana       African     1968       1541    HB       FRET
  Ansari et al., 2009 \[[@B23]\]             Pakistan    Asian       188        111     HB       ARMS PCR
  Trajkov et al., 2009 \[[@B24]\]            Macedonia   Caucasian   301        75      HB, PB   PCR-SSP
  Selvaraj et al., 2008 \[[@B25]\]           India       Asian       183        155     HB       ARMS PCR
  Wu et al., 2008 \[[@B26]\]                 China       Asian       111        183     PB       PCR RFLP
  Anand et al., 2007 \[[@B27]\]              India       Asian       143        132     HB       ARMS PCR
  Oh et al., 2007 \[[@B28]\]                 Korea       Asian       117        145     HB       ARMS PCR
  Amirzargar et al., 2006 \[[@B29]\]         Iran        Asian       123        41      HB       PCR-SSP
  Shin et al., 2005 \[[@B30]\]               Korea       Asian       871        459     HB       MAPA
  Scola et al., 2003 \[[@B31]\]              Italy       Caucasian   114        45      HB       ARMS PCR
  López-Maderuelo et al., 2003 \[[@B32]\]    Spain       Caucasian   100        113     HB       ARMS PCR
  Delgado et al., 2002 \[[@B33]\]            Cambodia    Asian       106        358     HB       PCR-SSP
  Bellamy et al., 1998 \[[@B34]\]            Gambia      African     408        401     HB       Hybridization

Abbreviations: ARMS PCR, amplification-refractory mutation system polymerase chain reaction; FRET, fluorescence resonance energy transfer; HB, hospital based; MAPA, multiplex automated primer extension analysis; PB, population based; PCR-SSP, polymerase chain reaction with a sequence specific primers.

###### Genotypic distribution of *IL-10* -1082 A\>G (rs1800896) gene polymorphism included in the meta-analysis

  First author and year     Controls   Cases                                           
  ------------------------- ---------- ------- ----- ------- ----- ----- ----- ------- ------
  Hu et al., 2015           262        196     22    0.250   82    34    4     0.175   0.35
  Feng et al., 2014         171        18      2     0.057   164   24    3     0.078   0.08
  Elorriaga et al., 2013    25         18      4     0.276   27    11    2     0.187   0.01
  Akgunes et al., 2011      17         13      0     0.216   15    9     6     0.350   0.26
  Liang et al., 2011        69         9       0     0.057   100   12    0     0.053   0.11
  Ansari et al., 2011       31         118     17    0.457   23    64    15    0.460   0.04
  Ben-Selma et al., 2011    60         26      9     0.231   30    33    13    0.388   0.01
  Taype et al., 2010        347        153     10    0.169   333   147   20    0.187   0.28
  Mosaad et al., 2010       8          88      2     0.469   0     16    10    0.692   0.13
  Thye et al., 2009         1048       783     140   0.269   794   630   117   0.280   0.27
  Ansari et al., 2009       32         136     20    0.468   21    71    19    0.490   0.03
  Trajkov et al., 2009      70         212     17    0.411   17    48    10    0.453   0.04
  Selvaraj et al., 2008     108        69      6     0.221   102   42    5     0.174   0.83
  Wu et al., 2008           104        18      0     0.073   48    12    1     0.114   0.98
  Anand et al., 2007        73         61      6     0.260   74    55    3     0.231   0.01
  Oh et al., 2007           45         53      19    0.388   98    43    4     0.175   0.95
  Amirzargar et al., 2006   18         79      5     0.436   7     31    2     0.437   0.04
  Shin et al., 2005         718        124     9     0.083   394   53    2     0.063   0.47
  Scola et al., 2003        13         77      24    0.548   6     22    17    0.622   0.05
  Maderuelo et al., 2003    21         50      29    0.540   33    47    33    0.501   0.91
  Delgado et al., 2002      39         64      3     0.330   86    259   11    0.394   0.06
  Bellamy et al., 1998      179        184     45    0.335   165   185   11    0.286   0.07

Abbreviations: HWE, Hardy--Weinberg equilibrium; MAF, minor allele frequency;.

###### Quality assessment conducted according to the NOS for all the studies included in the meta-analysis

  First author and year \[Ref.\]             Quality indicators          
  ------------------------------------------ -------------------- ------ --------
  Hu et al., 2015 \[[@B13]\]                 \*\*\*               \*     \*\*
  Feng et al., 2014 \[[@B14]\]               \*\*\*               \*     \*\*
  García-Elorriaga et al., 2013 \[[@B15]\]   \*\*\*               \*     \*\*
  Akgunes et al., 2011 \[[@B16]\]            \*\*                 \*     \*\*
  Liang et al., 2011 \[[@B17]\]              \*\*\*\*             \*\*   \*\*
  Ansari et al., 2011 \[[@B18]\]             \*\*\*               \*     \*\*
  Ben-Selma et al., 2011 \[[@B19]\]          \*\*\*\*             \*     \*\*
  Taype et al., 2010 \[[@B20]\]              \*\*\*\*             \*     \*\*
  Mosaad et al., 2010 \[[@B21]\]             \*\*\*               \*     \*\*
  Thye et al., 2009 \[[@B22]\]               \*\*\*\*             \*\*   \*\*
  Ansari et al., 2009 \[[@B23]\]             \*\*\*               \*     \*\*
  Trajkov et al., 2009 \[[@B24]\]            \*\*\*               \*     \*\*
  Selvaraj et al., 2008 \[[@B25]\]           \*\*\*\*             \*     \*\*
  Wu et al., 2008 \[[@B26]\]                 \*\*\*               \*     \*\*\*
  Prabhu Anand et al., 2007 \[[@B27]\]       \*\*\*               \*     \*\*\*
  Oh et al., 2007 \[[@B28]\]                 \*\*                 \*     \*\*
  Amirzargar et al., 2006 \[[@B29]\]         \*\*                 \*     \*\*
  Shin et al., 2005 \[[@B30]\]               \*\*\*\*             \*     \*\*
  Scola et al., 2003 \[[@B31]\]              \*\*                 \*     \*\*
  López-Maderuelo et al., 2003 \[[@B32]\]    \*\*\*               \*     \*\*
  Delgado et al., 2002 \[[@B33]\]            \*\*\*               \*\*   \*\*
  Bellamy et al., 1998 \[[@B34]\]            \*\*\*               \*     \*\*

Publication bias {#sec3-2}
----------------

Begg's funnel plot and Egger's test were performed to examine the publication bias among the selected studies for the present meta-analysis. The funnel plots were almost symmetric for both the Begg's test and Egger's test ([Figure 2](#F2){ref-type="fig"}). The findings showed lack of publication bias among all comparison models ([Table 4](#T4){ref-type="table"}).

![Funnel plot: Begg's Funnel plot for overall analysis.](bsr-37-bsr20170240-g2){#F2}

###### Statistics to test publication bias and heterogeneity in meta-analysis: overall analysis

  Comparisons      Egger's regression analysis   Heterogeneity analysis   Model used for the meta-analysis                             
  ---------------- ----------------------------- ------------------------ ---------------------------------- -------- ------- -------- --------
  G vs. A          0.134                         −1.53 to 1.80            0.868                              78.171   0.001   73.13    Random
  GG vs. AA        0.261                         −1.12 to 1.64            0.696                              60.855   0.001   67.135   Random
  AG vs. AA        −0.494                        −1.68 to 0.69            0.396                              48.356   0.001   56.572   Random
  GG + AG vs. AA   −0.293                        −1.63 to 1.04            0.651                              60.090   0.001   65.052   Random
  GG vs. AA + AG   0.420                         −1.10 to 1.94            0.570                              69.612   0.001   71.270   Random

Test of heterogeneity {#sec3-3}
---------------------

In order to test heterogeneity among the selected studies, *Q*-test and *I*^2^ statistics were employed. Significant heterogeneity was detected in all models. Therefore, random effects model was applied to synthesize the data ([Table 4](#T4){ref-type="table"}).

Sensitivity analysis {#sec3-4}
--------------------

Sensitivity analysis was performed to assess the influence of each individual study on the pooled OR by deleting one single study each time. The results showed that no individual affected the pooled OR significantly, suggesting stability of this meta-analysis ([Figure 3](#F3){ref-type="fig"}).

![Forest Plot: Sensitivity analysis for overall analysis.](bsr-37-bsr20170240-g3){#F3}

Quantitative synthesis {#sec3-5}
----------------------

We pooled all the 22 studies together which resulted into 4956 confirmed PTB cases and 6428 controls, for the assessment of overall association between the *IL-10* -1082 gene polymorphism and risk of developing PTB. The pooled ORs from the overall studies indicated no association with increased or decreased risk between *IL-10* -1082 A\>G gene polymorphism and PTB susceptibility in allelic contrast (G vs. A: *P*=0.985; OR = 1.001, 95% CI = 0.863--1.162), homozygous (GG vs. AA: *P*=0.889; OR = 1.029, 95% CI = 0.692--1.529), heterozygous (GA vs. AA: *P*=0.244; OR = 0.906, 95% CI = 0.767--1.070), dominant (GG + AG vs. AA: *P*=0.357; OR = 1.196, 95% CI = 0.817--1.752), and recessive (GG vs. AA + AG: *P*=0.364; OR = 0.921, 95% CI = 0.771--1.100) genetic models, respectively ([Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}).

![Forest plot: Overall analysis showing OR with 95% CI to evaluate the association of the *IL10* -1082 A\>G (rs1800871) gene polymorphism and PTB risk. Black squares represent the value of OR and the size of the square indicates the inverse proportion relative to its variance. Horizontal line is the 95% CI of OR.](bsr-37-bsr20170240-g4){#F4}

Subgroup analysis {#sec3-6}
-----------------

We have performed subgroup analysis based on ethnicity to explore the effect of ethnicity (Asian, African, and Caucasian) in the risk between *IL-10* -1082 A\>G and PTB risk.

Asian population {#sec3-7}
----------------

In Asian population, 13 studies were included and heterogeneity was observed in all the genetic models ([Table 5](#T5){ref-type="table"}). We performed analyses using random effect models for all the genetic models and no significant association of PTB susceptibility in all genetic models was detected in allele model (G vs. A: *P*=0.466; OR = 0.917, 95% CI = 0.726--1.158), homozygous model (GG vs. AA: *P*=0.602; OR = 0.853, 95% CI = 0.4710--1.547), heterozygous model (GA vs. AA: *P*=0.170; OR = 0.839, 95% CI = 0.652--1.078), dominant model (GG + AG vs. AA: GG vs. AA + AG: *P*=0.836; OR = 0.945, 95% CI = 0.554--1.613), and recessive model (GG vs. AA + AG: *P*=0.282; OR = 0.858, 95% CI = 0.650-- 1.134) ([Figure 5](#F5){ref-type="fig"}).

![Forest plot: Data from the Asian population showing OR with 95% CI to evaluate the association of the *IL10* -1082 A\>G (rs1800871) gene polymorphism and PTB risk. Black squares represent the value of OR and the size of the square indicates the inverse proportion relative to its variance. Horizontal line is the 95% CI of OR.](bsr-37-bsr20170240-g5){#F5}

###### Statistics to test publication bias and heterogeneity in the present meta-analysis: Asian population

  Comparisons    Egger's regression analysis   Heterogeneity analysis   Model used for the meta-analysis                             
  -------------- ----------------------------- ------------------------ ---------------------------------- -------- ------- -------- --------
  G vs. A        1.686                         −2.38 to 5.75            0.380                              44.674   0.001   73.139   Random
  GG vs. AA      1.018                         −1.08 to 3.88            0.446                              24.674   0.010   55.419   Random
  AG vs. AA      0.883                         −2.29 to 4.06            0.552                              28.851   0.004   58.409   Random
  GG+AG vs. AA   1.672                         −1.85 to 5.19            0.318                              37.372   0.001   67.890   Random
  GG vs. AA+AG   0.025                         −2.42 to 2.47            0.981                              22.603   0.020   51.334   Random

African population {#sec3-8}
------------------

In African population four studies were found. Publication bias was not significant but heterogeneity was found significant and conducted analyses using random effect models for all the genetic models ([Table 6](#T6){ref-type="table"}). We found no association with PTB risk in allele model (G vs. A: *P*=0.165; OR = 1.300, 95% CI = 0.898--1.883), homozygous model (GG vs. AA: *P*=0.569; OR = 1.407, 95% CI = 0.434--4.562), heterozygous model (GA vs. AA: *P*=0.128; OR = 1.101, 95% CI = 0.973--1.246), dominant model (GG + AG vs. AA: *P*=0.438; OR = 1.614, 95% CI = 0.482--5.412), and recessive model (GG vs. AA + AG: *P*=0.244; OR = 1.240, 95% CI = 0.863--1.783) genetic models ([Figure 6](#F6){ref-type="fig"}).

![Forest plot: Data from the African population showing OR with 95% CI to evaluate the association of the *IL10* -1082 A\>G (rs1800871) gene polymorphism and PTB risk. Black squares represent the value of OR and the size of the square indicates the inverse proportion relative to its variance. Horizontal line is the 95% CI of OR.](bsr-37-bsr20170240-g6){#F6}

###### Statistics to test publication bias and heterogeneity in the present meta-analysis: African population

  Comparisons      Egger's regression analysis   Heterogeneity analysis   Model used for the present meta-analysis                             
  ---------------- ----------------------------- ------------------------ ------------------------------------------ -------- ------- -------- --------
  G vs. A          2.415                         −7.48 to 12.31           0.403                                      21.824   0.001   86.254   Random
  GG vs. AA        1.047                         −11.12 to 13.21          0.746                                      26.345   0.001   88.613   Random
  AG vs. AA        1.562                         −2.28 to 5.40            0.222                                      6.646    0.084   54.862   Fixed
  GG + AG vs. AA   1.610                         −4.12 to 7.34            0.350                                      10.073   0.018   70.216   Random
  GG vs. AA + AG   1.486                         −13.42 to 16.40          0.709                                      35.484   0.001   91.545   Random

Caucasian population {#sec3-9}
--------------------

In Caucasian population four studies were included. Publication bias and heterogeneity were not significant, hence fixed effect models were applied for all the genetic models ([Table 7](#T7){ref-type="table"}). We potentially found association of PTB risk with dominant model (GG + AG vs. AA: *P*=0.004; OR = 1.694, 95% CI = 1.183-- 2.425). Whereas, other genetic models, i.e. allele (G vs. A: *P*=0.236; OR = 1.103, 95% CI = 0.938--1.298), homozygous model (GG vs. AA: *P*=0.098; OR = 1.439, 95% CI = 0.935--2.215), heterozygous model (GA vs. AA: *P*=0.446; OR = 0.915, 95% CI = 0.729--1.150), and recessive model (GG vs. AA + AG: *P*=0.926; OR = 0.990, 95% CI = 0.794--1.233) did not show any increased or decreased risk of PTB with *IL-10* -1082 A\>G gene polymorphism ([Figure 7](#F7){ref-type="fig"}).

![Forest plot: Data from the Caucasian population showing OR with 95% CI to evaluate the association of the *IL10* -1082 A\>G (rs1800871) gene polymorphism and PTB risk. Black squares represent the value of OR and the size of the square indicates the inverse proportion relative to its variance. Horizontal line is the 95% CI of OR.](bsr-37-bsr20170240-g7){#F7}

###### Statistics to test publication bias and heterogeneity in the present meta-analysis: Caucasian population

  Comparisons      Egger's regression analysis   Heterogeneity analysis   Model used for the present meta-analysis                            
  ---------------- ----------------------------- ------------------------ ------------------------------------------ ------- ------- -------- -------
  G vs. A          0.158                         −8.42 to 8.74            0.940                                      2.616   0.455   0.001    Fixed
  GG vs. AA        2.859                         −16.58 to 22.30          0.590                                      5.366   0.147   44.089   Fixed
  AG vs. AA        −1.361                        −4.15 to 1.42            0.170                                      2.446   0.485   00.001   Fixed
  GG + AG vs. AA   −1.031                        −4.68 to 2.62            0.348                                      2.235   2.235   0.5250   Fixed
  GG vs. AA + AG   8.205                         3.75 to 12.65            0.015                                      4.744   0.192   36.760   Fixed

Discussion {#sec4}
==========

Although various mechanisms have been described for the development of a protective immune response that restricts and controls the infection and thus prevents the progression of the active disease, the reasons underlying active disease progression remain poorly understood \[[@B41]\]. Candidate gene approach and association studies have identified various host genetic factors that affect the susceptibility to TB \[[@B41]\]. As an immune response modulator, IL-10 has a crucial role to suppress proinflammatory cytokine responses by the innate and adaptive immune systems \[[@B42]\]. *IL-10* is also thought to play an important regulatory role in many bacterial infections \[[@B43],[@B44]\]. Immunoregulatory genes are very important in modulating the host susceptibility to PTB because the first line of defense against *M. tuberculosis* involves the identification and uptake of the bacterium by macrophages and dendritic cells \[[@B45]\].

As we know that PTB is one of the most common infectious diseases with a high morbidity and mortality \[[@B1]\]. A well-established genetic marker surely would have a significant influence in screening and prevention of PTB. Cytokine polymorphism has been considered to be of important roles in host genetic factors. Among them, *IL-10* is an essential pleiotropic cytokine which takes part in immunoregulatory activities. Lately, *IL-10* gene has been widely studied and some studies suggested that the *IL-10* -1082 A\>G polymorphism is associated with PTB susceptibility, but the results are inconsistent. The results of studies generated could be having insufficient statistical power of individual studies with small sample sizes or variations that existed in different population. Therefore, we conducted this meta-analysis to provide more accurate statistical evidence of association between *IL-10* -1082 A\>G polymorphism and PTB susceptibility. Pooled ORs generated from large sample size and sufficient statistical power from various studies have the advantage of reducing random errors \[[@B46]\].

In the present study, we have included 22 studies with all the preset eligible criteria of sample size, genotype, inclusion criteria of PTB patients, and healthy controls. Most of the included studies scored five or more stars in NOS quality score assessment and suggested good to moderate quality by clearly stating about the sample size, genotype, inclusion criteria of PTB patients, and healthy controls.

Overall, we found that there was no association between *IL-10* -1082 A\>G polymorphism and PTB susceptibility under any genetic models in overall analysis.

These observations suggested that the *IL-10* -1082 A allele leads to increased resistance to PTB. Studies carried out on mice observed that overexpression of *IL-10* may not be important for susceptibility to initial infection with *M. tb* but may play a role in reactivation of the latent disease \[[@B47]\]. Other studies also reported no association between the said polymorphism and resistance to TB \[[@B48],[@B49]\].

During the subgroup analysis, we found that *IL-10* -1082 A\>G polymorphism has no role of increasing or decreasing PTB susceptibility in Asian and African populations. Interestingly, significant association was found with dominant model. This result implied that among different ethnicities, the same gene polymorphism may act differently in PTB susceptibility. Tuberculosis report clarified racial differences of susceptibility to TB \[[@B50]\]. Thus, the current results of the present study might attribute the racial differences and reflect the existence of racial differences of TB.

However, the susceptibility toward PTB is polygenic and multiple candidate genes are likely to be involved in determining resistance or susceptibility to TB \[[@B51]\]. Due to multifactorial nature of TB infection and complex nature of the immune system, *IL-10* -1082 A\>G genetic polymorphism cannot be solely responsible for the predisposition of PTB.

In the present study, significant heterogeneity was found between the selected studies in the test of heterogeneity. This discordance may be related to the ethnic origin of the patients as ethnicity-specific genetic variations may influence the host immunity to PTB. Nevertheless, some limitations also need to be addressed. First, we only included studies published in the English language, abstracted and indexed by the selected electronic databases were included for data analysis; it is possible that some pertinent studies published in other languages and indexed in other electronic databases may have missed. Second, the abstracted data were not stratified by other factors, e.g. HIV status or severity of the TB infection, and our results were based on unadjusted parameters. Third, we did not test for gene--environment interactions because of inadequate data available in the published reports. Despite above limitations, there are some advantages of the present study. First, the present meta-analysis was comprised with more number of studies which increased the statistical power of the study and ultimately reached at robust conclusion. Second, no publication bias was observed and further sensitivity analysis also supported our results more reliably.

Also, all the included studies were of good to modest quality fulfilling the preset needful criteria as tested by NOS quality score evaluation scale.

Conclusions {#sec5}
===========

In conclusion, this meta-analysis demonstrated that *IL-10* -1082 A\>G gene polymorphism is not associated with PTB risk in overall, Asian and African population. Our result provided evidence that G allele carrier is associated with PTB in Caucasian population. In the near future, because of significant public health impact of PTB, larger studies are warranted to identify the host genes with their functional allele controlling the response to mycobacterial infections. This will help in the identification of the host genetic factors for the susceptibility to PTB, and would greatly help in the global control of this infectious disease.
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CI

:   confidence interval

HWE

:   Hardy--Weinberg equilibrium

IFN-y

:   Interferon gamma

IL-10

:   interlukin-10

NOS

:   Newcastle--Ottawa Scale

OR

:   odds ratio

PTB

:   pulmonary tuberculosis

Th1

:   T helper 1

TNF-a

:   Tumor necrosis factor - alpha
